德良方药业七条生产线满负荷运转

Group 1 - The company, Guizhou Deliangfang Pharmaceutical Co., Ltd., is experiencing a strong production momentum at the beginning of the year, with all seven production lines operating at full capacity to meet increased demand for respiratory products before the Spring Festival [1] - The total order amount has exceeded 21 million yuan, with the main products, anti-inflammatory cough capsules and half-branch lotus capsules, accounting for more than half of the orders [1] - The company has over 20 years of experience in the ethnic medicine field, leveraging local natural resources to integrate Miao medicine prescriptions with modern technology, creating distinctive products like half-branch lotus capsules and Baihua grass capsules [1] Group 2 - Since the 14th Five-Year Plan, the company's production capacity has increased from approximately 8% to 17%, achieving a doubling effect [2] - The company plans to release production capacity to ensure the supply of key products while accelerating the development and launch of new products, including Class II medical devices and health foods, to cultivate new growth points by 2026 [2]